Outlook Therapeutics' Lytenava has become the first ophthalmic formulation of VEGF inhibitor bevacizumab to be cleared for use by the NHS in England and Wales for treating wet age-related macular ...
A stye is a tender, pus-filled lump on the eyelid caused by a bacterial infection in a clogged gland or eyelash follicle. Risk factors include poorly cleaned contact lenses, eye makeup buildup, and ...